Revvity | PKI - Debt


Revvity reported $3.35B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Agilent USD 3.35B 0 Dec/2025
Align Technology USD 116.04M 1.6M Mar/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 1.38B 7.9M Mar/2026
Bruker USD 1.67B 371.6M Mar/2026
Celltrion KRW 160.58B 733.3M Mar/2026
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Danaher USD 26.56B 8.07B Jun/2026
Dentsply International USD 2.33B 137M Mar/2026
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Illumina USD 2.54B 9M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 16.24B 408M Jun/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Laboratory Of America USD 7.24B 714.6M Mar/2026
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Mettler Toledo International USD 2.23B 76.47M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
OraSure Technologies USD 782K 465K Jun/2024
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Pharma Mar EUR 45.84M 1.7M Jun/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
Quest Diagnostics USD 6.41B 179M Mar/2026
Quidel USD 2.87B 40.8M Mar/2026
Repligen USD 690.94M 144.36M Jun/2026
Revvity USD 3.35B 48.03M Mar/2026
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Tilray USD 640.95M 35.17M Jun/2022
Waters USD 5.57B 4.08B Mar/2026
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026